Revolution Medicines (RVMD) Goodwill & Intangibles (2019 - 2026)

Revolution Medicines has reported Goodwill & Intangibles for 8 years, with the latest figure at $70.4 million in Q1 2026.

• For the quarter ending Q1 2026, Goodwill & Intangibles fell 0.85% year-over-year to $70.4 million; the trailing twelve-month figure through Mar 2026 stood at $70.4 million (down 0.85% YoY), and the FY2025 full-year result was $77.9 million, up 9.27% from the prior year.
• Goodwill & Intangibles for Q1 2026 stood at $70.4 million, down from $77.9 million in the prior quarter.
• The five-year high for Goodwill & Intangibles was $77.9 million in Q2 2022, with the low at $14.7 million in Q3 2025.
• Average Goodwill & Intangibles over 5 years is $70.0 million, with a median of $71.0 million recorded in 2025.
• Year-over-year, Goodwill & Intangibles rose 10.62% in 2022 and plunged 81.16% in 2025.
• Tracing RVMD's Goodwill & Intangibles over 5 years: stood at $70.4 million in 2022, then advanced by 10.62% to $77.9 million in 2023, then decreased by 8.49% to $71.3 million in 2024, then rose by 9.27% to $77.9 million in 2025, then decreased by 9.6% to $70.4 million in 2026.
• The last three Goodwill & Intangibles figures came in at $70.4 million (Q1 2026), $77.9 million (Q4 2025), and $14.7 million (Q3 2025), per Business Quant data.

Peer Comparison